business

J&J’s apalutamide cuts prostate cancer death risk by 20%

Investing.com · May 31, 2026, 12:33 PM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

ARY News Erleada: Prostate cancer drug reduces risk of spread and death CNBC A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China Healthline Colorectal, Thyroid Cancer Risk May Be Higher for Males With Infertility Healthline GLP-1 Drugs May Improve Breast Cancer Survival, Lower Risk of Recurrence

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

J&J’s apalutamide cuts prostate cancer death risk by 20%

Also covered by

More in business